CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue:
Premium revenue	$ 502,918	$ 458,962
ACO REACH revenue	$ 239,807	$ 182,797
Revenue, Product and Service [Extensible Enumeration]	Service [Member]	Service [Member]
Service revenue	$ 13,570	$ 12,392
Investment income (loss)	46	(40,888)
Total revenue	756,341	613,263
Operating expenses:
Medical costs	688,515	594,248
Operating costs	140,324	159,117
Restructuring charges	3,357	6,864
Depreciation and amortization	9,891	12,897
Total operating expenses	842,087	773,126
Operating loss	(85,746)	(159,863)
Interest expense	7,787	1,193
Other income	0	(784)
Loss from continuing operations before income taxes	(93,533)	(160,272)
Income tax expense	1,259	3,242
Net loss from continuing operations	(94,792)	(163,514)
Loss from discontinued operations, net of tax (Note 16)	(74,669)	(17,115)
Net Loss	(169,461)	(180,629)
Net earnings from continuing operations attributable to noncontrolling interests	(5,550)	(14,605)
Net loss attributable to Bright Health Group, Inc. common shareholders	$ (186,905)	$ (204,172)
Continuing operations, basic (in dollars per share)	$ (0.18)	$ (0.30)
Continuing operations, diluted (in dollars per share)	(0.18)	(0.30)
Discontinued operations, basic (in dollars per share)	(0.12)	(0.02)
Discontinued operations, diluted (in dollars per share)	(0.12)	(0.02)
Basic loss per share (in dollars per share)	(0.30)	(0.32)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.30)	$ (0.32)
Basic weighted-average common shares outstanding (in shares)	631,534	628,765
Diluted weighted-average common shares outstanding (in shares)	631,534	628,765
Series A preferred stock dividend accrued
Operating expenses:
Series A preferred stock dividend accrued	$ (9,714)	$ (8,938)
Series B preferred stock dividend accrued
Operating expenses:
Series A preferred stock dividend accrued	$ (2,180)	$ 0